Genenta Science S.p.A. Ownership 2024 | Who Owns Genenta Science S.p.A. Now?
Institutional Ownership
2.37%
Insider Ownership
38.68%
Retail Ownership
58.95%
Institutional Holders
4.00
Genenta Science S.p.A. Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CARTESIAN GROWTH CORP | 1.10% | 0.02% | 200,288 | 200,288 | 100.00% | 620,893 | Jun 30, 2024 |
ALGEBRIS (UK) LTD | 0.25% | 0.04% | 45,000 | - | - | 130,623 | Jun 30, 2024 |
UBS GROUP AG | 0.00% | - | 893 | 852 | 2078.05% | 2,768 | Jun 30, 2024 |
MORGAN STANLEY | 0.00% | - | 500 | - | - | 1,550 | Jun 30, 2024 |
BANK JULIUS BAER & CO. LTD, ZURICH | - | - | - | -385,313 | -100.00% | - | Jun 30, 2024 |
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ALGEBRIS (UK) LTD | 0.25% | 0.04% | 45,000 | - | - | 130,623 | Jun 30, 2024 |
CARTESIAN GROWTH CORP | 1.10% | 0.02% | 200,288 | 200,288 | 100.00% | 620,893 | Jun 30, 2024 |
UBS GROUP AG | 0.00% | - | 893 | 852 | 2078.05% | 2,768 | Jun 30, 2024 |
MORGAN STANLEY | 0.00% | - | 500 | - | - | 1,550 | Jun 30, 2024 |
BANK JULIUS BAER & CO. LTD, ZURICH | - | - | - | -385,313 | -100.00% | - | Jun 30, 2024 |
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CARTESIAN GROWTH CORP | 1.10% | 0.02% | 200,288 | 200,288 | 100.00% | 620,893 | Jun 30, 2024 |
UBS GROUP AG | 0.00% | - | 893 | 852 | 2078.05% | 2,768 | Jun 30, 2024 |
MORGAN STANLEY | 0.00% | - | 500 | - | - | 1,550 | Jun 30, 2024 |
ALGEBRIS (UK) LTD | 0.25% | 0.04% | 45,000 | - | - | 130,623 | Jun 30, 2024 |
BANK JULIUS BAER & CO. LTD, ZURICH | - | - | - | -385,313 | -100.00% | - | Jun 30, 2024 |
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BANK JULIUS BAER & CO. LTD, ZURICH | - | - | - | -385,313 | -100.00% | - | Jun 30, 2024 |
ALGEBRIS (UK) LTD | 0.25% | 0.04% | 45,000 | - | - | 130,623 | Jun 30, 2024 |
MORGAN STANLEY | 0.00% | - | 500 | - | - | 1,550 | Jun 30, 2024 |
UBS GROUP AG | 0.00% | - | 893 | 852 | 2078.05% | 2,768 | Jun 30, 2024 |
CARTESIAN GROWTH CORP | 1.10% | 0.02% | 200,288 | 200,288 | 100.00% | 620,893 | Jun 30, 2024 |
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CARTESIAN GROWTH CORP | 1.10% | 0.02% | 200,288 | 200,288 | 100.00% | 620,893 | Jun 30, 2024 |
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BANK JULIUS BAER & CO. LTD, ZURICH | - | - | - | -385,313 | -100.00% | - | Jun 30, 2024 |
Genenta Science S.p.A. Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 4 | - |
31 Dec, 23 | 4 | 33.33% |
30 Sep, 23 | 3 | -25.00% |
30 Jun, 23 | 4 | 100.00% |
31 Mar, 23 | 2 | -50.00% |
31 Dec, 22 | 4 | 100.00% |
30 Sep, 22 | 2 | -33.33% |
30 Jun, 22 | 3 | - |
31 Mar, 22 | 3 | 50.00% |
31 Dec, 21 | 2 | - |
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 430,854 | -6.41% |
31 Dec, 23 | 460,348 | 0.50% |
30 Sep, 23 | 458,047 | -0.15% |
30 Jun, 23 | 458,747 | 908.24% |
31 Mar, 23 | 45,500 | -7.25% |
31 Dec, 22 | 49,058 | 1290.53% |
30 Sep, 22 | 3,528 | -4.88% |
30 Jun, 22 | 3,709 | -92.17% |
31 Mar, 22 | 47,374 | 0.45% |
31 Dec, 21 | 47,163 | - |
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 2.37% | 37.04% |
31 Dec, 23 | 2.53% | 39.97% |
30 Sep, 23 | 2.51% | 39.65% |
30 Jun, 23 | 2.52% | 4036.19% |
31 Mar, 23 | 0.25% | 344.41% |
31 Dec, 22 | 0.27% | 71676.80% |
30 Sep, 22 | 0.02% | 3201.63% |
30 Jun, 22 | 0.02% | 24.93% |
31 Mar, 22 | 0.31% | 321.23% |
31 Dec, 21 | 0.31% | - |
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 1 | - |
30 Sep, 23 | - | -100.00% |
30 Jun, 23 | 2 | - |
31 Mar, 23 | - | -100.00% |
31 Dec, 22 | 3 | 200.00% |
30 Sep, 22 | 1 | -50.00% |
30 Jun, 22 | 2 | 100.00% |
31 Mar, 22 | 1 | -50.00% |
31 Dec, 21 | 2 | - |
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | 2 | - |
31 Dec, 23 | - | - |
30 Sep, 23 | - | - |
30 Jun, 23 | - | - |
31 Mar, 23 | - | - |
31 Dec, 22 | - | - |
30 Sep, 22 | - | -100.00% |
30 Jun, 22 | 1 | - |
31 Mar, 22 | 1 | - |
31 Dec, 21 | - | - |
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 4 | - | 430,854 | -6.41% | 2.37% | 37.04% | - | -100.00% | 2 | - |
31 Dec, 23 | 4 | 33.33% | 460,348 | 0.50% | 2.53% | 39.97% | 1 | - | - | - |
30 Sep, 23 | 3 | -25.00% | 458,047 | -0.15% | 2.51% | 39.65% | - | -100.00% | - | - |
30 Jun, 23 | 4 | 100.00% | 458,747 | 908.24% | 2.52% | 4036.19% | 2 | - | - | - |
31 Mar, 23 | 2 | -50.00% | 45,500 | -7.25% | 0.25% | 344.41% | - | -100.00% | - | - |
31 Dec, 22 | 4 | 100.00% | 49,058 | 1290.53% | 0.27% | 71676.80% | 3 | 200.00% | - | - |
30 Sep, 22 | 2 | -33.33% | 3,528 | -4.88% | 0.02% | 3201.63% | 1 | -50.00% | - | -100.00% |
30 Jun, 22 | 3 | - | 3,709 | -92.17% | 0.02% | 24.93% | 2 | 100.00% | 1 | - |
31 Mar, 22 | 3 | 50.00% | 47,374 | 0.45% | 0.31% | 321.23% | 1 | -50.00% | 1 | - |
31 Dec, 21 | 2 | - | 47,163 | - | 0.31% | - | 2 | - | - | - |
Genenta Science S.p.A. Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
Genenta Science S.p.A. Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|
Genenta Science S.p.A. Peer Ownership
Ticker | Company |
---|---|
CYT | Cyteir Therapeutics, Inc. |
PMVP | PMV Pharmaceuticals, Inc. |
MLYS | Mineralys Therapeutics, Inc. |
AVTE | Aerovate Therapeutics, Inc. |
CSBR | Champions Oncology, Inc. |
JANX | Janux Therapeutics, Inc. |
ANTX | AN2 Therapeutics, Inc. |
MNOV | MediciNova, Inc. |
PHVS | Pharvaris N.V. |
RZLT | Rezolute, Inc. |
PEPG | PepGen Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
ADAG | Adagene Inc. |
MOLN | Molecular Partners AG |
PRDS | Pardes Biosciences, Inc. |
OPT | Opthea Limited |
ELYM | Eliem Therapeutics, Inc. |
GNTA Ownership FAQ
Who Owns Genenta Science S.p.A.?
Genenta Science S.p.A. is owned by institutional shareholders (2.37%), insiders (38.68%), and public (58.95%). The largest institutional shareholder of Genenta Science S.p.A. is CARTESIAN GROWTH CORP (1.10% of total shares) and the top mutual fund owner is (0% of total shares).
Who are the major institutional shareholders of Genenta Science S.p.A.?
Genenta Science S.p.A.'s major institutional shareholders are CARTESIAN GROWTH CORP, ALGEBRIS (UK) LTD, UBS GROUP AG, MORGAN STANLEY, and BANK JULIUS BAER & CO. LTD, ZURICH. The top five shareholders own together 1.35% of the company's share outstanding.
How many Genenta Science S.p.A. shareholders are there?
As of Mar 2024, there are 4 institutional shareholders of Genenta Science S.p.A..
What percentage of Genenta Science S.p.A. is owned by CARTESIAN GROWTH CORP?
CARTESIAN GROWTH CORP owns 200.29K shares of Genenta Science S.p.A., representing 1.10% of the company's total shares outstanding, valued at $620.89K (as of Jun 2024).
What percentage of Genenta Science S.p.A. is owned by ALGEBRIS (UK) LTD?
As of Jun 2024, ALGEBRIS (UK) LTD holds 45K shares of Genenta Science S.p.A. (GNTA), compromising 0.25% of the company, valued at $130.62K.
What percentage of Genenta Science S.p.A. is owned by UBS GROUP AG?
UBS GROUP AG is the third largest holder of Genenta Science S.p.A.. The company owns 893 of the company's shares outstanding (worth $2.77K).